HEXAXIM

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE; HEPATITIS B VACCINES; PERTUSSIS TOXOID (PT); POLIOVIRUS TYPE 1 INACTIVATED; POLIOVIRUS TYPE 2 INACTIVATED; POLIOVIRUS TYPE 3 INACTIVATED; TETANUS PROTEIN CONJUGATE; TETANUS TOXOID

Dostupno od:

SANOFI ISRAEL LTD

ATC koda:

J07CA09

Farmaceutski oblik:

SUSPENSION FOR INJECTION

Sastav:

DIPHTHERIA TOXOID; TETANUS PROTEIN CONJUGATE 22 - 36 MCG / 0.5 ML; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE 12 MCG / 0.5 ML; HEPATITIS B VACCINES 10 MCG / 0.5 ML; POLIOVIRUS TYPE 3 INACTIVATED 32 DU / 0.5 ML; POLIOVIRUS TYPE 2 INACTIVATED 8 DU / 0.5 ML; POLIOVIRUS TYPE 1 INACTIVATED 40 DU / 0.5 ML; FILAMENTOUS HAEMAGGLUTININ (FHA) 25 MCG / 0.5 ML; PERTUSSIS TOXOID (PT) 25 MCG / 0.5 ML; TETANUS TOXOID

Administracija rute:

I.M

Tip recepta:

Required

Proizveden od:

SANOFI PASTEUR, FRANCE

Područje terapije:

DIPHTHERIA-HEMOPHILUS INFLUENZAE B-PERTUSSIS-POLIOMYELITIS-TETANUS-HEPATITIS B

Terapijske indikacije:

Hexaxim (DTaP-IPV-HB-Hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenza type b (Hib).The use of this vaccine should be in accordance with official recommendations.

Datum autorizacije:

2023-10-31